Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 50561 - 50580 out of 561067 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Australia | (R03DX10) benralizumab (adm: P) | Fasenra 30 mg/mL injection, 1 mL pen device | Injection 30 mg in 1 mL single dose pre-filled pen, 1 pcs | Ex-factory price without vat |
$0-0 |
$0-0 |
Asthma | AstraZenecaPtyLtd |
| Australia | (R03DX10) benralizumab (adm: P) | Fasenra 30 mg/mL injection, 1 mL pen device | Injection 30 mg in 1 mL single dose pre-filled pen, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Asthma | AstraZenecaPtyLtd |
| Australia | (R03DX10) benralizumab (adm: P) | Fasenra 30 mg/mL injection, 1 mL pen device | Injection 30 mg in 1 mL single dose pre-filled pen, 1 pcs | Ex-factory price without vat |
$0-0 |
$0-0 |
Asthma | AstraZenecaPtyLtd |
| Australia | (R03DX10) benralizumab (adm: P) | Fasenra 30 mg/mL injection, 1 mL pen device | Injection 30 mg in 1 mL single dose pre-filled pen, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Asthma | AstraZenecaPtyLtd |
| Australia | (R03DX10) benralizumab (adm: P) | Fasenra 30 mg/mL injection, 1 mL pen device | Injection 30 mg in 1 mL single dose pre-filled pen, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Asthma | AstraZenecaPtyLtd |
| Australia | (R03DX10) benralizumab (adm: P) | Fasenra 30 mg/mL injection, 1 mL pen device | Injection 30 mg in 1 mL single dose pre-filled pen, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Asthma | AstraZenecaPtyLtd |
| Australia | (R03DX10) benralizumab (adm: P) | Fasenra 30 mg/mL injection, 1 mL pen device | Injection 30 mg in 1 mL single dose pre-filled pen, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Asthma | AstraZenecaPtyLtd |
| Australia | (R03DX10) benralizumab (adm: P) | Fasenra 30 mg/mL injection, 1 mL pen device | Injection 30 mg in 1 mL single dose pre-filled pen, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Asthma | AstraZenecaPtyLtd |
| Australia | (R03DX10) benralizumab (adm: P) | Fasenra 30 mg/mL injection, 1 mL pen device | Injection 30 mg in 1 mL single dose pre-filled pen, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Asthma | AstraZenecaPtyLtd |
| Australia | (R03DX10) benralizumab (adm: P) | Fasenra 30 mg/mL injection, 1 mL pen device | Injection 30 mg in 1 mL single dose pre-filled pen, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Asthma | AstraZenecaPtyLtd |
| Australia | (R03DX10) benralizumab (adm: P) | Fasenra 30 mg/mL injection, 1 mL pen device | Injection 30 mg in 1 mL single dose pre-filled pen, 1 pcs | Ex-factory price without vat |
$0-0 |
$0-0 |
Asthma | AstraZenecaPtyLtd |
| Australia | (R03DX11) tezepelumab (adm: P) | Tezspire 210 mg/1.91 mL injection, 1.91 mL pen device | Solution for injection 210 mg in 1.91 mL single dose pre-filled pen (110 mg per mL), 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Asthma;Sinusitis | AstraZenecaPtyLtd |
| Australia | (R03DX11) tezepelumab (adm: P) | Tezspire 210 mg/1.91 mL injection, 1.91 mL pen device | Solution for injection 210 mg in 1.91 mL single dose pre-filled pen (110 mg per mL), 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Asthma;Sinusitis | AstraZenecaPtyLtd |
| Australia | (R03DX11) tezepelumab (adm: P) | Tezspire 210 mg/1.91 mL injection, 1.91 mL pen device | Solution for injection 210 mg in 1.91 mL single dose pre-filled pen (110 mg per mL), 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Asthma;Sinusitis | AstraZenecaPtyLtd |
| Australia | (R03DX11) tezepelumab (adm: P) | Tezspire 210 mg/1.91 mL injection, 1.91 mL pen device | Solution for injection 210 mg in 1.91 mL single dose pre-filled pen (110 mg per mL), 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Asthma;Sinusitis | AstraZenecaPtyLtd |
| Australia | (R03DX11) tezepelumab (adm: P) | Tezspire 210 mg/1.91 mL injection, 1.91 mL pen device | Solution for injection 210 mg in 1.91 mL single dose pre-filled pen (110 mg per mL), 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Asthma;Sinusitis | AstraZenecaPtyLtd |
| Australia | (R03DX11) tezepelumab (adm: P) | Tezspire 210 mg/1.91 mL injection, 1.91 mL pen device | Solution for injection 210 mg in 1.91 mL single dose pre-filled pen (110 mg per mL), 1 pcs | Ex-factory price without vat |
$0-0 |
$0-0 |
Asthma;Sinusitis | AstraZenecaPtyLtd |
| Australia | (R03DX11) tezepelumab (adm: P) | Tezspire 210 mg/1.91 mL injection, 1.91 mL pen device | Solution for injection 210 mg in 1.91 mL single dose pre-filled pen (110 mg per mL), 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Asthma;Sinusitis | AstraZenecaPtyLtd |
| Australia | (R03DX11) tezepelumab (adm: P) | Tezspire 210 mg/1.91 mL injection, 1.91 mL pen device | Solution for injection 210 mg in 1.91 mL single dose pre-filled pen (110 mg per mL), 1 pcs | Ex-factory price without vat |
$0-0 |
$0-0 |
Asthma;Sinusitis | AstraZenecaPtyLtd |
| Australia | (R05CB13) dornase alfa (desoxyribonuclease) (adm: Inhal.solution) | Pulmozyme 2.5 mg/2.5 mL inhalation solution, 30 x 2.5 mL ampoules | Solution for inhalation 2.5 mg (2,500 units) in 2.5 mL, 30 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | RocheProductsPtyLtd |
Pages
